Spots Global Cancer Trial Database for Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer.
Official Title: Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer: a Double Blind Randomized Clinical Trial
Study ID: NCT02468362
Conditions
Study Description
Brief Summary: Through a double blinded study, patients with low rectal cancer will be randomized into two equal groups to compare between the 5 year disease free survival as a primary outcome measure.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Osama Eldamshety, PhD, MD
Affiliation: Oncology centre of mansoura university
Role: PRINCIPAL_INVESTIGATOR
Name: Sherif Kotb, PhD, MD
Affiliation: Oncology centre of mansoura university
Role: PRINCIPAL_INVESTIGATOR
Name: Nazem Shams, PhD, MD
Affiliation: Oncology centre of mansoura university
Role: PRINCIPAL_INVESTIGATOR
Name: Ashraf Khater, Phd, MD
Affiliation: Oncology centre of mansoura university
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
